This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Fluvoxamine

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Fluvoxamine is a non-sedating highly specific antidepressant which inhibits the re-uptake of serotonin.

Fluvoxamine, like fluoxetine, is less cardiotoxic than tricyclic antidepressants such as amitriptyline and imipramine.

The dose of fluvoxamine is 50 mg twice daily, increasing to 100 mg twice daily after 10 days; the maximum recommended dose is 300 mg daily.

Side effects include nausea, constipation, agitation and weight loss.

Because of the agitation, doses are given in the mornings so as not to disturb sleep

There is controversy about an increased risk of suicide.

The summary of product characteristics should be consulted before prescribing this drug.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.